NEU1 Inhibitors and Risk of Malignancy: Mendelian Randomization Insights in Drug Targeting Studies

The Neu1 inhibitors significantly reduced the risk of gastric cancer, lung cancer, and cervical cancer

Authors

Publication Details

Journal
Alternative Complementary & Integrative Medicine
Published
2024-10-14
DOI
https://doi.org/10.24966/acim-7562/100519
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

NEU1 Inhibitors and Risk of Malignancy: Mendelian Randomization Insights in Drug Targeting Studies

Zhiwei Chen
Alternative Complementary & Integrative Medicine
Genomics and Rare Diseases
article

NEU1 Inhibitors and Risk of Malignancy: Mendelian Randomization Insights in Drug Targeting Studies

Zhiwei Chen
article en

Abstract

The Neu1 inhibitors significantly reduced the risk of gastric cancer, lung cancer, and cervical cancer

Alternative Complementary & Integrative MedicineVol. 10(7)
Good health and well-being
Openalex Percentile: Top 79%
Genomics and Rare Diseases
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

NEU1 Inhibitors and Risk of Malignancy: Mendelian Randomization Insights in Drug Targeting Studies — Zhiwei Chen · Alternative Complementary & Integrative Medicine (2024) | TGRS Research Map | TGRS